TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biopharma AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,163
|
2,531
|
2,620 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
334
|
83
|
369 |
| Total assets |
1,001
|
1,548
|
1,519 |
| Current assets |
1,001
|
1,548
|
1,519 |
| Current liabilities |
407
|
1,165
|
1,203 |
| Equity capital |
497
|
253
|
145 |
| - share capital |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
49.7%
|
16.3%
|
9.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
15.4%
|
3.3%
|
14.1% |
| Return on assets (ROA) |
33.4%
|
5.4%
|
24.3% |
| Current ratio |
245.9%
|
132.9%
|
126.3% |
| Return on equity (ROE) |
67.2%
|
32.8%
|
254.5% |
| Change turnover |
-208
|
49
|
-533 |
| Change turnover % |
-9%
|
2%
|
-17% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.